Cargando…

Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†

Continuous flow chemistry has the potential to greatly improve efficiency in the synthesis of active pharmaceutical ingredients (APIs); however, the optimization of these processes can be complicated by a large number of variables affecting reaction success. In this work, a screening design of exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Cameron T., Pritchard, Cailean Q., Cook, Daniel W., Ibrahim, Mariam, Desai, Bimbisar K., Whitham, Patrick J., Marquardt, Brian J., Chen, Yizheng, Zoueu, Jeremie T., Bortner, Michael J., Roper, Thomas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745113/
https://www.ncbi.nlm.nih.gov/pubmed/33456973
http://dx.doi.org/10.1039/c8re00252e
_version_ 1783624550386237440
author Armstrong, Cameron T.
Pritchard, Cailean Q.
Cook, Daniel W.
Ibrahim, Mariam
Desai, Bimbisar K.
Whitham, Patrick J.
Marquardt, Brian J.
Chen, Yizheng
Zoueu, Jeremie T.
Bortner, Michael J.
Roper, Thomas D.
author_facet Armstrong, Cameron T.
Pritchard, Cailean Q.
Cook, Daniel W.
Ibrahim, Mariam
Desai, Bimbisar K.
Whitham, Patrick J.
Marquardt, Brian J.
Chen, Yizheng
Zoueu, Jeremie T.
Bortner, Michael J.
Roper, Thomas D.
author_sort Armstrong, Cameron T.
collection PubMed
description Continuous flow chemistry has the potential to greatly improve efficiency in the synthesis of active pharmaceutical ingredients (APIs); however, the optimization of these processes can be complicated by a large number of variables affecting reaction success. In this work, a screening design of experiments was used to compare computational fluid dynamics (CFD) simulations with experimental results. CFD simulations and experimental results both identified the reactor residence time and reactor temperature as the most significant factors affecting product yield for this reaction within the studied design space. A point-to-point comparison of the results showed absolute differences in product yield as low as 2.4% yield at low residence times and up to 19.1% yield at high residence times with strong correlation between predicted and experimental percent yields. CFD was found to underestimate the product yields at low residence times and overestimate at higher residence times. The correlation in predicted product yield and the agreement in identifying significant factors in reaction performance reveals the utility of CFD as a valuable tool in the design of continuous flow tube reactors with significantly reduced experimentation.
format Online
Article
Text
id pubmed-7745113
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-77451132021-01-15 Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† Armstrong, Cameron T. Pritchard, Cailean Q. Cook, Daniel W. Ibrahim, Mariam Desai, Bimbisar K. Whitham, Patrick J. Marquardt, Brian J. Chen, Yizheng Zoueu, Jeremie T. Bortner, Michael J. Roper, Thomas D. React Chem Eng Article Continuous flow chemistry has the potential to greatly improve efficiency in the synthesis of active pharmaceutical ingredients (APIs); however, the optimization of these processes can be complicated by a large number of variables affecting reaction success. In this work, a screening design of experiments was used to compare computational fluid dynamics (CFD) simulations with experimental results. CFD simulations and experimental results both identified the reactor residence time and reactor temperature as the most significant factors affecting product yield for this reaction within the studied design space. A point-to-point comparison of the results showed absolute differences in product yield as low as 2.4% yield at low residence times and up to 19.1% yield at high residence times with strong correlation between predicted and experimental percent yields. CFD was found to underestimate the product yields at low residence times and overestimate at higher residence times. The correlation in predicted product yield and the agreement in identifying significant factors in reaction performance reveals the utility of CFD as a valuable tool in the design of continuous flow tube reactors with significantly reduced experimentation. The Royal Society of Chemistry 2019-01-30 /pmc/articles/PMC7745113/ /pubmed/33456973 http://dx.doi.org/10.1039/c8re00252e Text en © 2019 The Royal Society of Chemistry http://creativecommons.org/licenses/by/3.0/ This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Armstrong, Cameron T.
Pritchard, Cailean Q.
Cook, Daniel W.
Ibrahim, Mariam
Desai, Bimbisar K.
Whitham, Patrick J.
Marquardt, Brian J.
Chen, Yizheng
Zoueu, Jeremie T.
Bortner, Michael J.
Roper, Thomas D.
Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
title Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
title_full Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
title_fullStr Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
title_full_unstemmed Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
title_short Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
title_sort continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745113/
https://www.ncbi.nlm.nih.gov/pubmed/33456973
http://dx.doi.org/10.1039/c8re00252e
work_keys_str_mv AT armstrongcameront continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT pritchardcaileanq continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT cookdanielw continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT ibrahimmariam continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT desaibimbisark continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT whithampatrickj continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT marquardtbrianj continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT chenyizheng continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT zoueujeremiet continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT bortnermichaelj continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach
AT roperthomasd continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach